Vnitr Lek 2009, 55(2):91-96

Midterm results aortic valve replacement with allograft

A. Mokráček^1,*, J. Špatenka², H. Pospíšilová¹, M. Šulda¹, R. Tesařík¹, M. Vambera¹, Š. Šindelářová¹, F. Toušek¹, M. Šetina³, J. Vojáček⁴, V. Lánská⁵, L. Pešl¹

¹ Kardiocentrum Nemocnice České Budějovice, a.s., ředitel MUDr. Ladislav Pešl

² Transplantcentrum FN Motol Praha, přednosta MUDr. Jaroslav Špatenka, CSc.

³ Kardiochirurgické oddělení FN Motol, Praha, přednosta doc. MUDr. Marek Šetina, CSc.

⁴ Kardiochirurgická klinika Lékařské fakulty UK a FN Hradec Králové, přednosta doc. MUDr. Jan Harrer, CSc.

⁵ Oddělení lékařské statistiky IKEM Praha, vedoucí RNDr. Věra Lánská, CSc.

Introduction:
Aortic allograft implantation into the aortic position in adults is standard procedure with some controversary. The most popular indication is bacterial endocarditis. We would like to present our midterm results.

Results:
We implanted 61 allografts in 60 patients (between 10/2002 and 04/2008). Men were 46 (76.8%) and average age was 57 ± 10.76 year. 30 days mortality was 9 people (15.0%, all with bacterial endocarditis). Late mortality 1 man (1.6%). Follow up 1-66 months, average 39.18 SD ± 14.3 months, median 42 months.

Conclusion:
Implantation of aortic allograft into the aortic position is standard procedure with good midterm results. Relative high early mortality is dependent on preoperative status in patiens with acute bacterial endocarditis - all early death people were people with acute bacterial endocarditis and minimally one vital organ severe dysfunction.

Keywords: allograft; endocarditis; aortic valve

Received: October 15, 2008; Accepted: November 18, 2008; Published: February 1, 2009  Show citation